3 results about "Herpes Labialis" patented technology

The application discloses a kind of enveloped virus inactivation preparation based on medium-chain triglyceride and application thereof, the present application relates to the technical field of biological medicine external preparation, including active ingredient and auxiliary material: the active ingredient includes: high-purity medium-chain triglyceride (MCT), preferably octanoic acid (C8) and capric acid (C10) triglyceride mixture, purity ≥99%; The auxiliary material includes: food-grade antioxidant, for preventing oxidation of preparation, the content of food-grade antioxidant is 0.01-0.05%w / w, with medium-chain triglyceride as active ingredient, through the physical and chemical synergistic effect, enveloped virus is efficiently killed, for treating stubborn skin mucosa infection diseases (such as stubborn flat warts, herpes labialis, genital herpes, etc.) caused by human papillomavirus (HPV), herpes simplex virus (HSV-1 / HSV-2), varicella-zoster virus and other enveloped viruses.

The invention belongs to the technical field of biomedicine, and particularly relates to camphor gel for treating herpes labialis and a preparation method thereof. Aiming at the problems of poor solubility, insufficient stability, strong skin irritation and the like of the existing camphor gel, the light liquid paraffin can be used as a unique solvent to dissolve camphor and other oily components, the gel is realized by adding colloidal silicon dioxide in stages, the aloe gel and / or sodium pyruvate can be selectively added to improve the functionality, and the prepared camphor gel can be used for preparing the oil-in-water gel. And the ethanol content or no ethanol content in the final product is controlled. The camphor gel prepared by the invention has good physical stability and skin compatibility, can effectively avoid the problems of layering, drug precipitation, skin irritation and the like, and provides a safer and more effective treatment choice for patients with herpes labialis.

The present invention further relates to a composition comprising methanesulfonic acid and a non-aqueous proton acceptor for use in a method for the treatment and management of one or more of fistula, pilonidal sinus, herpes labialis, pyogenic granuloma, fungal nail infection and onicocriptosis.